glp 1 drug makers Market Overview: GLP-1 Agonists and the Obesity Market | Blog How GLP-1 weight loss drugs

other second-line GLD (n = 23,661)

Overall pipeline momentum is unprecedented for metabolic disease

doi: 10.2337/diacare.27.11.2628 53 ApovianCMBergenstalRMCuddihyRMQuYLenoxSLewisMSet al

however, based on thyroid C-cell hyperplasia, adenomas, and medullary thyroid carcinomas observed in studies of these agents in mice (40), all of the GLP-1 receptor agonists except exenatide BID and lixisenatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma and in patients with multiple endocrine neoplasia syndrome type 2 (1418)

Ozempic is part of a group of drugs called glucagon-like peptide-1 receptor agonists (GLP-1s) and contains the active ingredient semaglutide

Patients taking Zepbound, which contains a GLP-1 agonist, may be at higher risk of developing NAION